Dapagliflozin治疗组(n = 55)

安慰剂组(n = 50)

性别n(%)

男性n(%)

27 (49.1%)

23 (46.0%)

女性

28 (50.9%)

27 (54.0%)

BMI n(%)

≥18.5, <24

19 (34.5%)

18 (36.0%)

≥24, <27

20 (36.4%)

19 (38.0%)

≥27

16 (29.1%)

13 (26.0%)

收缩压n(%)

≥140 mmhg

32 (58.2%)

23 (46.0%)

<140 mmhg

23 (41.8%)

27 (54.0%)